Opioid-Related

Listing Kratom As Schedule I Will Impede Research Opportunities

Listing Kratom As Schedule I Will Impede Research Opportunities

By

The DEA's plan to list kratom as a Schedule I controlled substance would make researching the possible opioid substitute much more difficult.

FDA Starts App Competition To Help Reduce Overdose Mortality

FDA Starts App Competition To Help Reduce Overdose Mortality

By

No application is currently available to connect carriers of naloxone with nearby opioid overdose victims.

Sign Up for Free e-newsletters